- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hepatocellular Carcinoma, Non-cirrhotic Liver in United Kingdom
Total 4689 results
-
Arbor Research Collaborative for HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedEnd Stage Liver Disease | Liver Diseases | Liver Cirrhosis | Hepatitis C | Hepatocellular CancerUnited States, Canada
-
CASI Pharmaceuticals, Inc.CompletedAdvanced Adult Hepatocellular Carcinoma | Advanced Fibrolamellar CarcinomaUnited States
-
TriSalus Life Sciences, Inc.Active, not recruitingHepatocellular Carcinoma | Intrahepatic CholangiocarcinomaUnited States
-
AbbVieRecruitingHepatocellular CarcinomaUnited States, Japan, Taiwan, Korea, Republic of, Spain, France, Italy
-
Chugai PharmaceuticalCompletedAdvanced or Metastatic HCCUnited States
-
AstraZenecaActive, not recruitingHepatocellular CarcinomaUnited States, Canada, Brazil, France, Italy, Russian Federation, Spain, Vietnam, Korea, Republic of, China, Germany, Ukraine, Japan, Hong Kong, Taiwan, India, Thailand
-
Daiichi Sankyo, Inc.ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...CompletedHepatocellular CarcinomaUnited States, France, Italy, Germany, Spain, Switzerland, Belgium, Portugal, Netherlands, Australia, Brazil, Canada, Austria, New Zealand, Sweden, Argentina
-
Eli Lilly and CompanyCompletedHepatocellular CarcinomaUnited States, Canada, Belgium, Germany, Israel, Korea, Republic of, Spain, Australia, Austria, Brazil, France, Italy, Japan, Portugal, Taiwan, Romania, Bulgaria, Czech Republic, Finland, Hong Kong, Hungary, Netherlands, Norway, Phili... and more
-
Nottingham University Hospitals NHS TrustRecruitingLiver Diseases | Liver FibrosisUnited Kingdom
-
Bristol-Myers SquibbCompletedHepatocellular CarcinomaUnited States, Argentina, Australia, Canada, China, France, Hong Kong, Italy, Japan, Korea, Republic of, Taiwan, Thailand, Spain
-
St. Louis UniversitySuspendedBariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver TransplantationObesity | HCC | Body Weight | Hepatocellular Carcinoma | Hepatitis C | Weight Loss | CirrhosisUnited States
-
Novartis PharmaceuticalsCompletedCarcinomaChina, Italy, Taiwan, Germany, Hungary, Belgium, Spain, Australia, Austria, France, Hong Kong, Thailand, Korea, Republic of, Canada, Japan, Israel, United States, Greece
-
VA Office of Research and DevelopmentNot yet recruitingHepatocellular CarcinomaUnited States
-
AstraZenecaRecruitingHepatocellular CarcinomaSpain, Canada, Germany, Belgium, United States, France, Italy, Japan, China, Egypt, India, Russian Federation, Taiwan, Vietnam, Thailand, Saudi Arabia, Portugal, Korea, Republic of, Brazil, Malaysia, Mexico, Philippines, Puerto Rico
-
University Hospital Southampton NHS Foundation...National Institute for Health Research, United KingdomCompletedNon-Alcoholic Fatty Liver DiseaseUnited Kingdom
-
University of EdinburghNHS LothianCompletedNon Alcoholic Fatty Liver DiseaseUnited Kingdom
-
AstraZenecaRecruitingHepatocellular Carcinoma | Biliary Tract CancerChina, Spain, Korea, Republic of, Italy, United Kingdom, United States, Japan, Taiwan, Hong Kong
-
Novartis PharmaceuticalsCompletedHepatocellular CarcinomaUnited States, Taiwan, Germany, Italy, Hong Kong, Canada, Japan, Spain
-
Intercept PharmaceuticalsCompletedNonalcoholic Steatohepatitis | Compensated CirrhosisUnited States, Spain, France, Australia, New Zealand, Puerto Rico, Germany, Canada, United Kingdom, Hungary, Poland, Ukraine
-
Bruce A. GriffinImperial College London; University of CambridgeCompletedNon-alcoholic Fatty Liver Disease (NAFLD)United Kingdom
-
AstraZenecaActive, not recruitingHepatocellular CarcinomaUnited States, Canada, France, Taiwan, Thailand, Vietnam, Italy, Korea, Republic of, Brazil, India, Japan, Mexico, Russian Federation, China, Hong Kong, Australia, Spain, Singapore
-
Massachusetts General HospitalTerminatedHepatocellular CancerUnited States
-
Can-Fite BioPharmaCompletedHepatocellular CarcinomaUnited States, Israel, Bulgaria, Romania, Serbia
-
Matthew ArmstrongQueen Elizabeth Hospital NHS Foundation TrustCompletedLiver Cirrhosis | Liver DysfunctionUnited Kingdom
-
Novartis PharmaceuticalsCompletedCompensated Cirrhosis and Portal HypertensionUnited Kingdom
-
Stanford UniversityNational Cancer Institute (NCI)TerminatedRecurrent Hepatocellular Carcinoma | Child-Pugh Class A | Child-Pugh Class BUnited States, Japan
-
AstraZenecaCompletedNon-Cirrhotic Non-alcoholic Steatohepatitis With FibrosisDenmark, Italy, Spain, United States, Argentina, Sweden, Mexico, Norway, Portugal
-
Fast Forward PharmaceuticalsUnknownPrimary Biliary CirrhosisNetherlands, United Kingdom
-
Imperial College LondonCompleted
-
Boehringer IngelheimCompletedCarcinoma, HepatocellularAustria, France, Germany, Hungary, Netherlands, Poland, Romania, United Kingdom
-
AstraZenecaParexelCompletedNon-alcoholic SteatohepatitisUnited Kingdom
-
William Beaumont HospitalsTerminatedFibrosis, Liver | Cirrhosis, Liver | Steatohepatitis, Nonalcoholic | Fatty Liver DiseaseUnited States
-
University of Missouri-ColumbiaPenn State UniversityCompletedHepatocellular CancerUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingHepatocellular Carcinoma | Liver CancerUnited States, Canada, Germany, France, Russian Federation, Argentina, Australia, Austria, Belgium, Brazil, Chile, Colombia, Hong Kong, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Puerto Rico, Romania, Sing... and more
-
St. Joseph Hospital of OrangeWithdrawn
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bracco Diagnostics, IncCompletedHepatocellular CarcinomaUnited States
-
University of NottinghamCompletedLiver FibrosisUnited Kingdom
-
Guy's and St Thomas' NHS Foundation TrustKing's College London; Medical Research Council; Guts UKRecruitingNon-Alcoholic Fatty Liver DiseaseUnited Kingdom
-
Queen Mary University of LondonKing's College Hospital NHS Trust; Barts & The London NHS Trust; Homerton University...RecruitingNon-Alcoholic Fatty Liver DiseaseUnited Kingdom
-
Anwaar SaeedAstraZeneca; ExelixisActive, not recruitingHepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Esophageal AdenocarcinomaUnited States
-
Kyowa Kirin, Inc.Bristol-Myers SquibbCompletedCarcinoma | HCC | Cancer | Hepatocellular Carcinoma | Solid TumorUnited States
-
Polaris GroupTerminatedGlioma | Hepatocellular Carcinoma | Uveal Melanoma | Sarcomatoid Carcinoma | Pleural Mesothelioma Malignant Advanced | Peritoneal Mesothelioma Malignant Advanced | Non-squamous Non-small Cell Lung CarcinomaUnited States, United Kingdom
-
Washington University School of MedicineXcovery Holding Company, LLCTerminatedHepatocellular Carcinoma | Gastric Cancer | Solid Tumor | Gastroesophageal Junction AdenocarcinomaUnited States
-
Novartis PharmaceuticalsAllerganCompletedNon-alcoholic Steatohepatitis (NASH)United States, Belgium, Spain, Canada, Argentina, Israel, Germany, France, Italy, Turkey, Singapore, Russian Federation, United Kingdom, Czechia, Egypt, India, Latvia
-
AstraZenecaRecruitingA Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma (ATHENA)Hepatocellular CarcinomaUnited States, Korea, Republic of
-
King's College Hospital NHS TrustNot yet recruitingLiver Diseases | Liver CirrhosisUnited Kingdom
-
ImunonCompletedHepatocellular CarcinomaUnited States, Taiwan, Korea, Republic of, China, Italy, Hong Kong, Thailand, Canada, Malaysia, Japan, Philippines
-
University of OxfordActive, not recruitingNon-Alcoholic Fatty Liver DiseaseUnited Kingdom
-
Imperial College LondonKing's College LondonCompletedNon-Alcoholic Fatty Liver Disease | Fecal Microbiota TransplantationUnited Kingdom